Top

Reactions Weekly

Published in:

01-03-2021 | NSCLC | Case report

Antineoplastics

Raised creatinine, ALT and AST levels, and drug resistance: case report

Published in: Reactions Weekly | Issue 1/2021

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Urbanska EM, et al. Changing ALK-TKI-Resistance Mechanisms in Rebiopsies of ALK-Rearranged NSCLC: ALK- and BRAF-Mutations Followed by Epithelial-Mesenchymal Transition. International Journal of Molecular Sciences 21: No. 8, 2020. Available from: URL: http://doi.org/10.3390/ijms21082847

Title: Antineoplastics
Raised creatinine, ALT and AST levels, and drug resistance: case report
Publication date: 01-03-2021
Publisher: Springer International Publishing
Keywords: NSCLC
Metastasis
NSCLC
Alectinib
Ceritinib
Crizotinib
Lorlatinib
Published in: Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-92287-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Antineoplastics

Raised creatinine, ALT and AST levels, and drug resistance: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Alendronic acid/denosumab/ibandronic acid

Digoxin

Nonsteroidal anti-inflammatory drugs

Multiple drugs

Erdafitinib/ergocalciferol/multivitamin

Lower risk of severe hypoglycaemia with insulin glargine or detemir